EF
ABBV icon

Elite Financial’s AbbVie ABBV Stock Holding History

Elite Financial’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$316K Sell
1,453
-100
-6% -$22.2K 0.14% 44
2025
Q4 		$354K Hold
1,553
– – 0.16% 43
2025
Q3 		$339K Sell
1,553
-1,128
-42% -$230K 0.16% 43
2025
Q2 		$528K Sell
2,681
-225
-8% -$41.8K 0.26% 36
2025
Q1 		$608K Sell
2,906
-651
-18% -$127K 0.32% 31
2024
Q4 		$632K Buy
+3,557
New +$654K 0.34% 30

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Elite Financial's ABBV Position: Q1 2026 in Review

Elite Financial reduced its AbbVie (ABBV) stake by 6.4% in Q1 2026, selling an estimated $22.2K and leaving 1,453 shares worth $316K. The position accounts for 0.14% of the portfolio, ranked #44.

Elite Financial first reported a position in ABBV in Q4 2024 and has held it in 6 quarters since. The position peaked at $632K in Q4 2024. 4,078 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Elite Financial held 1,453 shares of AbbVie worth $316K as of Q1 2026.
  • Elite Financial sold 100 AbbVie shares in Q1 2026, an estimated $22.2K.
  • AbbVie made up 0.14% of Elite Financial's portfolio in Q1 2026, its #44 holding.
  • Elite Financial first reported a position in AbbVie in Q4 2024 and has held it in 6 quarters since.
  • Elite Financial's AbbVie position peaked at $632K in Q4 2024.
  • 4,078 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Elite Financial's 13F filing for Q1 2026, filed 12 May 2026.